The HMGA2-IMP2 Pathway Promotes Granulosa Cell Proliferation in Polycystic Ovary Syndrome

Overview

Journal J Clin Endocrinol Metab

Publisher Oxford University Press

Specialty Endocrinology

Date 2018 Sep 25

PMID 30247605

Citations 25

Authors

Miao Li

Han Zhao

Shi-Gang Zhao

Dai-Min Wei

Yue-Ran Zhao

Tao Huang

Tahir Muhammad

Lei Yan

Fei Gao

Lei Li

Gang Lu

Wai-Yee Chan

Peter C K Leung

Andrea Dunaif

Hong-Bin Liu

Zi-Jiang Chen

Affiliations

Soon will be listed here.

Abstract

Context: The high mobility group AT hook 2 (HMGA2) gene was previously identified in a genome-wide association study as a candidate risk gene that might be related to polycystic ovary syndrome (PCOS). Whether HMGA2 contributes to promoting granulosa cell (GC) proliferation in PCOS remains unknown.

Objective: We sought to determine whether HMGA2 is involved in the ovarian dysfunction of PCOS and in the mechanism of increased GC proliferation.

Patients And Cells: mRNA expression was analyzed in ovarian GCs from 96 women with PCOS and 58 healthy controls. Immortalized human GCs (KGN and SVOG cells) were used for the mechanism study.

Main Outcome Measures: mRNA expression in ovarian GCs was measured using quantitative RT-PCR, and KGN cells were cultured for proliferation assays after overexpression or knockdown of target genes. Protein expression analysis, luciferase assays, and RNA binding protein immunoprecipitation assays were used to confirm the mechanism study.

Results: HMGA2 and IGF2 mRNA binding protein 2 (IMP2) were highly expressed in the GCs of women with PCOS, and the HMGA2/IMP2 pathway promoted GC proliferation. Cyclin D2 and SERPINE1 mRNA binding protein 1 were regulated by IMP2 and were highly expressed in women with PCOS.

Conclusions: The HMGA2/IMP2 pathway was activated in women with PCOS and promoted the proliferation of GCs. This might provide new insights into the dysfunction of GCs in PCOS.

Citing Articles

Transcriptome profiling reveals dysregulation of inflammatory and protein synthesis genes in PCOS.

Li X, Gao B, Gao B, Li X, Xia X Sci Rep. 2024; 14(1):16596.

PMID: 39025980 PMC: 11258128. DOI: 10.1038/s41598-024-67461-4.

Exploration of the Polymorphism Distribution of Bovine Gene in Worldwide Breeds and Its Associations with Ovarian Traits.

Shen S, Zhu L, Yang Y, Bi Y, Li J, Wang Y Animals (Basel). 2024; 14(5).

PMID: 38473181 PMC: 10930529. DOI: 10.3390/ani14050796.

HMGA2 overexpression activates IGF2BP2 to stabilize APLP2 via m6A modification and promote pancreatic cancer progression.

Liu K, Wei C, Yu H, Zhang Q, Du Z Heliyon. 2024; 10(5):e27268.

PMID: 38449630 PMC: 10915557. DOI: 10.1016/j.heliyon.2024.e27268.

MALAT1 expression in granulosa cells in PCOS patients with different phenotypes.

Li S, Li Y, Yan X, Zhao S, Yang Z, Wang Y Sci Rep. 2024; 14(1):5019.

PMID: 38424234 PMC: 10904732. DOI: 10.1038/s41598-024-55760-9.

High levels of fatty acid-binding protein 5 excessively enhances fatty acid synthesis and proliferation of granulosa cells in polycystic ovary syndrome.

Liu J, Li J, Wu X, Zhang M, Yan G, Sun H J Ovarian Res. 2024; 17(1):44.

PMID: 38373971 PMC: 10875862. DOI: 10.1186/s13048-024-01368-6.

References

Iwase A, Goto M, Harata T, Takigawa S, Nakahara T, Suzuki K . Insulin attenuates the insulin-like growth factor-I (IGF-I)-Akt pathway, not IGF-I-extracellularly regulated kinase pathway, in luteinized granulosa cells with an increase in PTEN. J Clin Endocrinol Metab. 2009; 94(6):2184-91. DOI: 10.1210/jc.2008-1948. View

Christiansen J, Kolte A, Hansen T, Nielsen F . IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes. J Mol Endocrinol. 2009; 43(5):187-95. DOI: 10.1677/JME-09-0016. View

Stubbs S, Stark J, Dilworth S, Franks S, Hardy K . Abnormal preantral folliculogenesis in polycystic ovaries is associated with increased granulosa cell division. J Clin Endocrinol Metab. 2007; 92(11):4418-26. DOI: 10.1210/jc.2007-0729. View

. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1):19-25. DOI: 10.1016/j.fertnstert.2003.10.004. View

Schmittgen T, Livak K . Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3(6):1101-8. DOI: 10.1038/nprot.2008.73. View

McAllister J, Legro R, Modi B, Strauss 3rd J . Functional genomics of PCOS: from GWAS to molecular mechanisms. Trends Endocrinol Metab. 2015; 26(3):118-24. PMC: 4346470. DOI: 10.1016/j.tem.2014.12.004. View

HUGHESDON P . Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis". Obstet Gynecol Surv. 1982; 37(2):59-77. DOI: 10.1097/00006254-198202000-00001. View

Li Z, Zhang Y, Ramanujan K, Ma Y, Kirsch D, Glass D . Oncogenic NRAS, required for pathogenesis of embryonic rhabdomyosarcoma, relies upon the HMGA2-IGF2BP2 pathway. Cancer Res. 2013; 73(10):3041-50. PMC: 3732831. DOI: 10.1158/0008-5472.CAN-12-3947. View

Vendola K, Zhou J, Adesanya O, Weil S, Bondy C . Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest. 1998; 101(12):2622-9. PMC: 508852. DOI: 10.1172/JCI2081. View

10.

Hayes M, Urbanek M, Ehrmann D, Armstrong L, Lee J, Sisk R . Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun. 2015; 6:7502. PMC: 4557132. DOI: 10.1038/ncomms8502. View

11.

Mahajan A, Liu Z, Gellert L, Zou X, Yang G, Lee P . HMGA2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma. Mod Pathol. 2010; 23(5):673-81. DOI: 10.1038/modpathol.2010.49. View

12.

Franks S, Mason H, Willis D . Follicular dynamics in the polycystic ovary syndrome. Mol Cell Endocrinol. 2000; 163(1-2):49-52. DOI: 10.1016/s0303-7207(99)00239-7. View

13.

Erickson G, Magoffin D, Garzo V, Cheung A, Chang R . Granulosa cells of polycystic ovaries: are they normal or abnormal?. Hum Reprod. 1992; 7(3):293-9. DOI: 10.1093/oxfordjournals.humrep.a137638. View

14.

Sicinski P, Donaher J, Geng Y, Parker S, Gardner H, Park M . Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature. 1996; 384(6608):470-4. DOI: 10.1038/384470a0. View

15.

Chen Z, Zhao H, He L, Shi Y, Qin Y, Shi Y . Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2010; 43(1):55-9. DOI: 10.1038/ng.732. View

16.

Dai N, Zhao L, Wrighting D, Kramer D, Majithia A, Wang Y . IGF2BP2/IMP2-Deficient mice resist obesity through enhanced translation of Ucp1 mRNA and Other mRNAs encoding mitochondrial proteins. Cell Metab. 2015; 21(4):609-21. PMC: 4663978. DOI: 10.1016/j.cmet.2015.03.006. View

17.

Jiang L, Huang J, Li L, Chen Y, Chen X, Zhao X . MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome. J Clin Endocrinol Metab. 2015; 100(5):E729-38. PMC: 4422895. DOI: 10.1210/jc.2014-3827. View

18.

Gallardo T, John G, Shirley L, Contreras C, Akbay E, Haynie J . Genomewide discovery and classification of candidate ovarian fertility genes in the mouse. Genetics. 2007; 177(1):179-94. PMC: 2013718. DOI: 10.1534/genetics.107.074823. View

19.

Hillier S . Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod. 1994; 9(2):188-91. DOI: 10.1093/oxfordjournals.humrep.a138480. View

20.

Reeves R, Nissen M . The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J Biol Chem. 1990; 265(15):8573-82. View